For Immediate Release
Chicago, IL – November 16, 2023 – Stocks in this week’s article are Cboe Global Markets (
CBOE Quick Quote CBOE - Free Report) , Parker-Hannifin Corp. ( PH Quick Quote PH - Free Report) , Microsoft Corp. ( MSFT Quick Quote MSFT - Free Report) , FedEx Corp. ( FDX Quick Quote FDX - Free Report) and Cardinal Health Inc. ( CAH Quick Quote CAH - Free Report) . 5 Top Dividend-Growth Stocks for Your Portfolio
Dividend investing remains a popular choice among investors, irrespective of market conditions. This strategy focuses on companies that not only pay dividends but also consistently increase them over time. This approach offers a unique blend of income and growth potential, appealing to a broad range of investors, from those seeking steady income to those aiming for long-term capital appreciation. Additionally, it can provide a sense of security in times of market uncertainty or downturns.
In fact, stocks with a strong history of year-over-year dividend growth form a healthy portfolio with a greater scope of capital appreciation, as opposed to simple dividend-paying stocks or those that have high yields. We have selected five dividend growth stocks —
Cboe Global Markets, Parker-Hannifin Corp., Microsoft Corp., FedEx Corp. and Cardinal Health Inc. — that could be solid choices for your portfolio. Why Dividend Growth Strategy?
Stocks that have a strong history of dividend growth belong to mature companies, which are less susceptible to large swings in the market and thus act as a hedge against economic or political uncertainty as well as stock market volatility. At the same time, these offer downside protection with their consistent increase in payouts.
Additionally, these stocks have superior fundamentals that make dividend growth a quality and promising investment for the long term. These include a sustainable business model, a long track of profitability, rising cash flows, good liquidity, a strong balance sheet and some value characteristics. Further, a history of strong dividend growth indicates that a dividend increase is likely in the future.
Although these stocks do not necessarily have the highest yields, they have outperformed for a longer period than the broader stock market or any other dividend-paying stock.
Here are five of the 12 stocks that fit the bill:
Cboe Global is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. The company saw a positive earnings estimate revision of 3 cents over the past seven days for this year. It delivered an average earnings surprise of 4.07% for the past four quarters.
Cboe Global has a Zacks Rank #1 and a Growth Score of B. You can see
. the complete list of today’s Zacks #1 Rank stocks here
Parker-Hannifin is a global diversified manufacturer of motion & control technologies and systems. It provides precision-engineered solutions for a wide variety of mobile, industrial and aerospace markets. The stock saw a solid earnings estimate revision of a couple of cents over the past seven days for the fiscal year ending June 2024 and has an estimated earnings growth rate of 5.3%.
Parker-Hannifin has a Zacks Rank #2 and a Growth Score of B.
Microsoft is one of the largest broad-based technology providers in the world. The company dominates the PC software market, with more than 73% of the market share for desktop operating systems. Microsoft saw a positive earnings estimate revision of a couple of cents for the fiscal year (ending June 2024) over the past seven days. It has an estimated earnings growth rate of 13.46%
Microsoft has a Zacks Rank #2 and a Growth Score of A.
FedEx is the leader in global express delivery services. It provides a broad portfolio of transportation, e-commerce and business services through companies competing collectively, operating independently and managing collaboratively under the FedEx brand. FedEx has an estimated earnings growth rate of 21.26% for the fiscal year (ending May 2024) and delivered an average earnings surprise of 16.94% for the past four quarters.
FDX has a Zacks Rank #2 and a Growth Score of B.
Cardinal Health is a nationwide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company saw a positive earnings estimate revision of 4 cents over the past seven days for the fiscal year (ending June 2024), with an expected earnings growth rate of 17.79%.
Cardinal Health has a Zacks Rank #2 and a Growth Score of A.
You can get the remaining stock on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
. Click here to sign up for a free trial to the Research Wizard today For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2184424/5-top-dividend-growth-stocks-for-your-portfolio Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance . Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of
+46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation. See Stocks Free >>
Follow us on Twitter:
Join us on Facebook:
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer.
www.zacks.com/disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.